SMTL ID : 8qn5.4 (3 other biounits)

M. tuberculosis salicylate synthase MbtI in complex with methyl-AMT (new crystal form)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.54 Å

Oligo State

monomer

Ligands

1 x 0GA: 3-{[(1Z)-1-carboxyprop-1-en-1-yl]oxy}-2-hydroxybenzoic acid(Non-covalent)

0GA.1: 10 residues within 4Å: Chain A: P.252, E.253, A.270, T.362, Y.386, L.405, R.406, A.419, G.420, K.439 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:P.252, A:T.362, A:L.405, A:K.439 Hydrogen bonds: A:Y.386, A:Y.386, A:R.406, A:R.406, A:R.406, A:G.420, A:K.439 Water bridges: A:L.269, A:A.270 Salt bridges: A:K.439, A:K.439 pi-Cation interactions: A:K.439

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 7 residues within 4Å: Chain A: V.215, P.216, F.217, A.218, G.413, R.414, T.415 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.415, A:T.415

1 x FLC: CITRATE ANION(Non-covalent)

FLC.3: 5 residues within 4Å: Chain A: R.139, G.155, I.156, R.157, H.158 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:R.139, A:G.155, A:R.157, A:R.157, A:H.158 Water bridges: A:T.140, A:I.156, A:I.156, A:H.158 Salt bridges: A:R.139, A:R.139, A:H.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mori, M. et al., Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery. Pharmaceuticals (2023)

Release Date

2023-11-15

Peptides

Salicylate synthase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Salicylate synthase

Related Entries With Identical Sequence